245 related articles for article (PubMed ID: 19689164)
1. The effect of migraine prophylaxis on migraine-related resource use and productivity.
Láinez MJ
CNS Drugs; 2009 Sep; 23(9):727-38. PubMed ID: 19689164
[TBL] [Abstract][Full Text] [Related]
2. Topiramate in migraine prophylaxis: long-term impact on resource utilization and cost.
Silberstein SD; Feliu AL; Rupnow MF; Blount AC; Boccuzzi SJ
Headache; 2007 Apr; 47(4):500-10. PubMed ID: 17445099
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of topiramate in migraine prevention: results from a pharmacoeconomic model of topiramate treatment.
Brown JS; Papadopoulos G; Neumann PJ; Friedman M; Miller JD; Menzin J
Headache; 2005 Sep; 45(8):1012-22. PubMed ID: 16109115
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of migraine prevention: the case of topiramate in the UK.
Brown JS; Papadopoulos G; Neumann PJ; Price M; Friedman M; Menzin J
Cephalalgia; 2006 Dec; 26(12):1473-82. PubMed ID: 17116098
[TBL] [Abstract][Full Text] [Related]
5. Persistence with migraine prophylactic treatment and acute migraine medication utilization in the managed care setting.
Yaldo AZ; Wertz DA; Rupnow MF; Quimbo RM
Clin Ther; 2008 Dec; 30(12):2452-60. PubMed ID: 19167603
[TBL] [Abstract][Full Text] [Related]
6. Topiramate for migraine prophylaxis.
Drug Ther Bull; 2006 Aug; 44(8):62-4. PubMed ID: 16903488
[TBL] [Abstract][Full Text] [Related]
7. Cost-minimization analysis comparing topiramate with standard treatments in migraine prophylaxis.
Ergun H; Gulmez SE; Tulunay FC
Eur Neurol; 2007; 58(4):215-7. PubMed ID: 17827966
[TBL] [Abstract][Full Text] [Related]
8. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
[TBL] [Abstract][Full Text] [Related]
9. Resource utilization impact of topiramate for migraine prevention in the managed-care setting.
Wertz DA; Quimbo RM; Yaldo AZ; Rupnow MF
Curr Med Res Opin; 2009 Feb; 25(2):499-503. PubMed ID: 19192995
[TBL] [Abstract][Full Text] [Related]
10. Topiramate for migraine prophylaxis.
Fontebasso M
Expert Opin Pharmacother; 2007 Nov; 8(16):2811-23. PubMed ID: 17956201
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of antiepileptic drugs in migraine prophylaxis.
Adelman JU; Adelman LC; Von Seggern R
Headache; 2002; 42(10):978-83. PubMed ID: 12453029
[TBL] [Abstract][Full Text] [Related]
12. Resource use associated with topiramate in migraine prophylaxis.
Feliu AL; Rupnow MF; Blount A; Boccuzzi SJ; Vermilyea J
Am J Health Syst Pharm; 2007 Jul; 64(14):1483-91. PubMed ID: 17617498
[TBL] [Abstract][Full Text] [Related]
13. The cost of migraine and its treatment.
Goldberg LD
Am J Manag Care; 2005 Jun; 11(2 Suppl):S62-7. PubMed ID: 16095269
[TBL] [Abstract][Full Text] [Related]
14. Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications.
Cady RK; Voirin J; Farmer K; Browning R; Beach ME; Tarrasch J
Headache; 2012 May; 52(5):749-64. PubMed ID: 22188311
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of interventions for migraine in four low- and middle-income countries.
Linde M; Steiner TJ; Chisholm D
J Headache Pain; 2015 Feb; 16():15. PubMed ID: 25869942
[TBL] [Abstract][Full Text] [Related]
16. Topiramate as an adjunctive treatment in migraine prophylaxis.
Martínez HR; Londoño O; Cantú-Martínez L; del Carmen Tarín L; Castillo CD
Headache; 2003; 43(10):1080-4. PubMed ID: 14629243
[TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness of pharmacotherapy for the prevention of migraine: a Markov model application.
Yu J; Smith KJ; Brixner DI
CNS Drugs; 2010 Aug; 24(8):695-712. PubMed ID: 20658800
[TBL] [Abstract][Full Text] [Related]
18. Cost effectiveness of topiramate in the prevention of migraines in the United States: an update.
Brown JS; Rupnow MF; Neumann P; Friedman M; Menzin J
Manag Care Interface; 2006 Dec; 19(12):31-8. PubMed ID: 17274479
[TBL] [Abstract][Full Text] [Related]
19. Topiramate for migraine prevention.
Wenzel RG; Schwarz K; Padiyara RS
Pharmacotherapy; 2006 Mar; 26(3):375-87. PubMed ID: 16503717
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
